Correlating structure and ligand affinity in drug discovery: a cautionary tale involving second shell residues.
Tziridis, A., Rauh, D., Neumann, P., Kolenko, P., Menzel, A., Brauer, U., Ursel, C., Steinmetzer, P., Sturzebecher, J., Schweinitz, A., Steinmetzer, T., Stubbs, M.T.(2014) Biol Chem 395: 891-903
- PubMed: 25003390 
- DOI: https://doi.org/10.1515/hsz-2014-0158
- Primary Citation of Related Structures:  
3PLB, 3PLK, 3PLP, 3PM3, 3PMJ, 3PWB, 3PWC, 3PYH, 3Q00, 3UNQ, 3UNS, 3UOP, 3UPE, 3UQO, 3UQV, 3UUZ, 3UWI, 3UY9, 3V12, 3V13 - PubMed Abstract: 
A high-resolution crystallographic structure determination of a protein-ligand complex is generally accepted as the 'gold standard' for structure-based drug design, yet the relationship between structure and affinity is neither obvious nor straightforward ...